Illinois 104th General Assembly Status: Introduced 5 D cosponsors

SB3323      — CONTROLLED SUB-TESTOSTERONE

Last action — Rule 3-9(a) / Re-referred to Assignments

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced February 03, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Amends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.

Bill Text

We don't have the full text on file for this bill yet.

Read SB3323 on the official Illinois source →

Action History

  1. Rule 3-9(a) / Re-referred to Assignments

  2. Added as Co-Sponsor Sen. Graciela Guzmán

  3. Rule 2-10 Committee Deadline Established As April 24, 2026

  4. Added as Co-Sponsor Sen. Emil Jones, III

  5. Added as Co-Sponsor Sen. Mary Edly-Allen

  6. Rule 2-10 Committee Deadline Established As March 27, 2026

  7. Assigned to Executive

  8. Added as Co-Sponsor Sen. Rachel Ventura

  9. Referred to Assignments

  10. First Reading

  11. Filed with Secretary by Sen. Adriane L. Johnson

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 178 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (178)

178 members have not signed on to this bill.

Show all 178 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB3323      do?
Amends the Illinois Controlled Substances Act. Provides that the Prescription Monitoring Program does not apply to testosterone, mifepristone, misoprostol, GnRH analogues, or estrogen. Provides that the Department of Human Services shall purge from the records of the Prescription Monitoring Program all existing information concerning the prescribing or dispensing of testosterone, including any such information contained in the central repository or database, on or before January 1, 2027, and shall ensure that no further records concerning the prescribing and dispensing of testosterone are created or maintained by the Prescription Monitoring Program. Provides that the Department shall update and adopt rules consistent with the provision no later than January 1, 2027. Effective immediately.
Who sponsors SB3323     ?
SB3323      is sponsored by Adriane L. Johnson (Democrat), Rachel Ventura (Democrat), Mary Edly-Allen (Democrat), Emil Jones, III (Democrat), and Graciela Guzmán (Democrat).
What is the current status of SB3323     ?
This bill has been introduced in the Senate. Introduced February 03, 2026. It must pass committee before a floor vote.
Where can I track SB3323     ?
Track SB3323      free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB3323     

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB3323     

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →